Form D · Other Health Care

DexCare, Inc.

Seattle, WA · CIK 0001843308

Offering snapshot reported Sep 14, 2026 · SEC filing

Reported sold
$12.9M
Offering amount: $22.7M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 28, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 14, 2026Initial$12,929,562No comparison14SEC filing
Jun 27, 2023Initial$47,189,230No comparison10SEC filing
Mar 10, 2021Initial$19,999,997No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-597399

Source: Form D, filed Sep 14, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Blosl Director, Executive
Lynne Chou O'keefe Director
Delos Cosgrove Director
Toby Cosgrove Director
Todd Cozzens Director
Branden Fini Director
David Kereiakes Director
Aaron Martin Director
Paul Minardi Director
Lynne Chou O'keefe Director
Lynne Chou O?Keefe Director
Derek Streat Director, Executive
Caroline Xie Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1522 Western Ave., #24336
Seattle, WA, 98101